文献速递分子诊断临床微生物

分子方法检测志贺菌及在治疗研究中推断表型耐药的应用

Use of Molecular Methods To Detect Shigella and Infer Phenotypic Resistance in a Shigella Treatment Study.
PubMed 文献 · J Clin Microbiol · 2021-10-20

该研究在孟加拉国一项志贺菌治疗研究中检测673份粪便标本,包括154份培养阳性标本及其配对志贺菌分离株,使用含24种肠道病原体和36个抗菌药物耐药基因的TaqMan阵列卡。qPCR检测志贺菌的阳性率(49%)显著高于培养(23%),对分离株耐药基因检测与表型药敏相比,阿奇霉素和氨苄西林的敏感性和特异性均>94%,但直接粪便标本耐药基因检测预测配对分离株耐药的特异性较低。

要点

  • qPCR检测志贺菌阳性率49%,显著高于培养的23%(P<0.05)。
  • 分离株耐药基因qPCR对阿奇霉素和氨苄西林药敏的敏感性和特异性均>94%。
  • 直接粪便检测ermB或mphA预测阿奇霉素耐药特异性仅56%,但阴性预测值91%。

核心结论

  • 直接粪便标本分子诊断大幅提高志贺菌检出率,包括既往使用抗生素者。
  • 直接粪便标本耐药基因检测确认耐药特异性低,但可能排除大环内酯类耐药。

研究设计与样本

  • 研究检测673份来自孟加拉国志贺菌治疗研究的粪便标本,含154份培养阳性标本及配对分离株。
  • 使用TaqMan阵列卡,包含24种肠道病原体和36个抗菌药物耐药基因的qPCR检测。

主要发现

  • 培养检出志贺菌23%(154/673),qPCR检出腹泻相关量49%(329/673;P<0.05)。
  • 分离株耐药基因qPCR与表型药敏相比,阿奇霉素和氨苄西林的敏感性和特异性均>94%。
  • 复方磺胺甲噁唑药敏的检测性能较差,环丙沙星因多数分离株耐药而评估受限。
  • 直接粪便标本耐药基因检测预测配对分离株耐药的特异性普遍较低,而预测敏感的敏感性和阴性预测值常较高。
  • 粪便中ermB或mphA检测预测配对分离株阿奇霉素耐药:特异性56%,敏感性91%,阴性预测值91%。

关键数值与推荐

  • qPCR检测志贺菌阳性率49%(329/673) vs 培养23%(154/673),P<0.05。
  • 分离株耐药基因qPCR对阿奇霉素和氨苄西林药敏的敏感性和特异性均>94%。
  • 粪便ermB或mphA预测阿奇霉素耐药:特异性56%,敏感性91%,阴性预测值91%。
  • 就诊前使用阿奇霉素者培养阳性0/112(0%),qPCR阳性34/112(30%)。

临床怎么用

  • 分子方法可提高志贺菌检出,尤其适用于既往使用抗生素的患者。
  • 直接粪便耐药基因检测可用于排除大环内酯类耐药,但不宜单独确认耐药。

局限性

  • 复方磺胺甲噁唑药敏的分子检测性能较差。
  • 环丙沙星因多数分离株耐药而评估受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Molecular diagnostic methods improve the detection of Shigella, yet their ability to detect Shigella drug resistance on direct stool specimens is less clear. We tested 673 stool specimens from a Shigella treatment study in Bangladesh, including 154 culture-positive stool specimens and their paired Shigella isolates. We utilized a TaqMan array card that included quantitative PCR (qPCR) assays for 24 enteropathogens and 36 antimicrobial resistance (AMR) genes. Shigella was detected by culture in 23% of stool specimens (154/673), while qPCR detected Shigella at diarrhea-associated quantities in 49% (329/673; P < 0.05). qPCR for AMR genes on the Shigella isolates yielded >94% sensitivity and specificity compared with the phenotypic susceptibility results for azithromycin and ampicillin. The performance for trimethoprim-sulfamethoxazole susceptibility was less robust, and the assessment of ciprofloxacin was limited because most isolates were resistant. The detection of AMR genes in direct stool specimens generally yielded low specificities for predicting the resistance of the paired isolate, whereas the sensitivity and negative predictive values for predicting susceptibility were often higher. For example, the detection of ermB or mphA in stool yielded a specificity of 56% but a sensitivity of 91% and a negative predictive value of 91% versus the paired isolate's azithromycin resistance result. Patients who received azithromycin prior to presentation were universally culture negative (0/112); however, qPCR still detected Shigella at diarrhea-associated quantities in 34/112 (30%). In sum, molecular diagnostics on direct stool specimens greatly increase the diagnostic yield for Shigella, including in the setting of prior antibiotics. The molecular detection of drug resistance genes in direct stool specimens had low specificity for confirming resistance but could potentially "rule out" macrolide resistance.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Pholwat S, Liu J, Taniuchi M, et al. Use of Molecular Methods To Detect Shigella and Infer Phenotypic Resistance in a Shigella Treatment Study. J Clin Microbiol. 2021. PMID: 34669456. doi:10.1128/JCM.01774-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。